Vaccines for Humans: Research funded by the European Union

Europe has a long and successful tradition for vaccine research in both public and private institutions. Two-thirds of global vaccine R&D is being conducted by European organisations and almost 90% of all vaccine production takes
place in Europe. Europe is therefore well positioned to take on new challenges in vaccine research, and exploit the
immense opportunities that are opening up in this field of science. The European Commission’s Sixth Framework
Programme for Research (FP6) has been an important catalyst in this direction and has provided substantial momentum to further advance the European activities in vaccine research.

This publication compiles the projects on human vaccine research that were initiated during FP6 (2002-2006). Most of the projects have been funded through the Health theme of FP6, although important contributions came from the Food theme, the Information Society theme (IST) and from cross-cutting activities on international cooperation (INCO), and the support activities to small and medium-sized enterprises (COOP). Many of the projects will not conclude before 2009 or later, but they are already beginning to deliver important results. Taken together they provide evidence of a vibrant, visionary and ambitious research community, where hundreds of scientists are working together to discover and develop new vaccines for the world.